At FutuRx we transform science into therapeutic breakthroughs.

FutuRx was founded by Johnson & Johnson Innovation – JJDC, Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc.-TVI and OrbiMed Israel Partners together with the Israeli Innovation Authority of the Ministry of Economy and later joined by Leaps by Bayer, the impact investments unit of Bayer AG.

The FutuRx incubator is dedicated to the inception of early-stage biopharma ventures based on cutting edge science and supporting them in successful drug development.